…attributed to the web-based program? Do you believe the Mahana Therapeutics website should also mention that 30% of the trial participants did not provide these 12-month responses, so their IBS-SSS…
…the reported improvements should be attributed to the web-based program? To be fully transparent, do you believe the website should also mention that 30% of the trial participants did not…
…responses on the symptom severity measure, the IBS-SSS, from the trial. It is hard to get around the stubborn facts: On the IBS-SSS, the difference at 12 months between the…
…is a blood cancer. And so we would screen these drugs and put them through our pipeline in the laboratory, to try and get them into clinical trials. And back…
…nothing to do with treating the illness itself. Moreover, this was an unblinded trial relying solely on self-reported rather than objective outcomes. Since this kind of study design is likely…
…the gathering, I was scheduled to give a talk today in Sheffield, where I previously spoke about the PACE trial. This talk was slated to be about so-called “medically unexplained…
